Previous Page  9 / 12 Next Page
Information
Show Menu
Previous Page 9 / 12 Next Page
Page Background

Page 24

Notes:

Journal of Clinical and Experimental Toxicology | Volume: 03 | ISSN: 2630-4570

allied

academies

November 04-05, 2019 | Prague, Czech Republic

2

nd

World Congress on

TOXICOLOGY AND APPLIED PHARMACOLOGY

Berberine as multi-targets therapeutic weapon against Alzheimer's disease

Doaa A Ghareeb

Alexandria University, Egypt

I

t is well known that berberine has several biological

activities like antioxidants, anti-inflammatory, antidiabetic,

antilipidemic and antitumor properties. Unfortunately,

this compound does not use as drug because it has low

bioavailability moreover, the plant that contains this

compound is not cultivated in Egypt. The aim of this study

was to understand the function of berberine as a treatment

for Alzheimer. To achieve this aim, the anti-Alzheimer/

anticancer effect of this compound at in silico,

in vitro

and

in vivo

level through targeting several pathways implicated

in disorder incidence and progression was investigated.

Moreover, two approaches in medical biotechnology

field were used to resolve berberine problems which are

Biocatalysis and nano-formulations. In conclusion, berberine

loaded nanoparticle is good candidate to treat Alzheimer

through targeting several pathways with no-toxic effect and

high therapeutic index.

Biography

Doaa A Ghareeb is the professor of clinical biochemistry at Faculty of

Science, Alexandria University. She is the Acting Dean of Pharmaceutical

and Fermentation Industries Development Centre, City of Scientific

Research and Technological Applications and the Manger of Biological

Screening and Preclinical Trial Lab, Department of Biochemistry,

Faculty of Science, Alexandria University. She is a member of National

committee of Women in Science, Academy of Scientific Research

and Technology, Egypt. She is the co-founder and director of Drug

Preclinical Studies Center of Excellency. She is among the founding

members of Egyptian Association for Cancer Research. Her h-index is 14

and published about 66 articles in peer-reviewed journals and attended

more than 80 national and international workshops and conferences

in different medical biotechnology field. She supervised more than 60

Master and PhD students from Egypt, and other countries and has been

serving as an editorial board member of reputed Journals.

e:

d.ghareeb@yahoo.com

Doaa A Ghareeb, J Clin Exp Tox, Volume: 03

DOI: 10.35841/2630-4570-C2-008